<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">aspirin</td><td>Aspirin</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">Non-steroidal anti-inflammatory agent (FN)</td><td>NSAIDs</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD (7600)</span><br/>Reviewed date:[REDACTED] 12:10:12 PM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING<br/>NON-FASTING</td></tr><tr><td ID="result1_attr1">CHOLESTEROL, TOTAL</td><td>223</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result1_attr2">HDL CHOLESTEROL</td><td>85</td><td>&gt; OR = 50 mg/dL</td><td/></tr><tr><td ID="result1_attr3">TRIGLYCERIDES</td><td>60</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result1_attr4">LDL-CHOLESTEROL</td><td>123</td><td/><td ID="result1_attr4_notes"><p>Reference range: &lt;100</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>calculation, which is a validated novel method providing</p><p>LDL-C is now calculated using the [REDACTED]</p><p>estimation of LDL-C.</p><p>better accuracy than the Friedewald equation in the</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result1_attr5">CHOL/HDLC RATIO</td><td>2.6</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result1_attr6">NON HDL CHOLESTEROL</td><td>138</td><td>&lt;130 mg/dL (calc)</td><td ID="result1_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>option.</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p></td></tr><tr><td colspan="4"><span class="content_span">THYROID PANEL WITH TSH (7444)</span><br/>Reviewed date:[REDACTED] 12:10:12 PM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result2_attr1">T3 UPTAKE</td><td>31</td><td>22-35 %</td><td/></tr><tr><td ID="result2_attr2">T4 (THYROXINE), TOTAL</td><td>5.0</td><td>5.1-11.9 mcg/dL</td><td/></tr><tr><td ID="result2_attr3">FREE T4 INDEX (T7)</td><td>1.6</td><td>1.4-3.8</td><td/></tr><tr><td ID="result2_attr4">TSH</td><td>2.06</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 12:10:13 PM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING<br/>NON-FASTING</td></tr><tr><td ID="result3_attr1">GLUCOSE</td><td>88</td><td>65-99 mg/dL</td><td ID="result3_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result3_attr2">UREA NITROGEN (BUN)</td><td>16</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result3_attr3">CREATININE</td><td>0.67</td><td>0.60-0.95 mg/dL</td><td/></tr><tr><td ID="result3_attr4">EGFR</td><td>87</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result3_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result3_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result3_attr6">SODIUM</td><td>140</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result3_attr7">POTASSIUM</td><td>4.0</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result3_attr8">CHLORIDE</td><td>104</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result3_attr9">CARBON DIOXIDE</td><td>29</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result3_attr10">CALCIUM</td><td>9.9</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result3_attr11">PROTEIN, TOTAL</td><td>7.5</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result3_attr12">ALBUMIN</td><td>4.3</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result3_attr13">GLOBULIN</td><td>3.2</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result3_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.3</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result3_attr15">BILIRUBIN, TOTAL</td><td>0.4</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result3_attr16">ALKALINE PHOSPHATASE</td><td>41</td><td>37-153 U/L</td><td/></tr><tr><td ID="result3_attr17">AST</td><td>17</td><td>10-35 U/L</td><td/></tr><tr><td ID="result3_attr18">ALT</td><td>13</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 12:10:13 PM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result4_attr1">WHITE BLOOD CELL COUNT</td><td>3.8</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result4_attr2">RED BLOOD CELL COUNT</td><td>4.40</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result4_attr3">HEMOGLOBIN</td><td>13.4</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result4_attr4">HEMATOCRIT</td><td>40.9</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result4_attr5">MCV</td><td>93.0</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result4_attr6">MCH</td><td>30.5</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result4_attr7">MCHC</td><td>32.8</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result4_attr8">RDW</td><td>13.0</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result4_attr9">PLATELET COUNT</td><td>187</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result4_attr10">MPV</td><td>11.2</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result4_attr11">ABSOLUTE NEUTROPHILS</td><td>1311</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result4_attr12">ABSOLUTE LYMPHOCYTES</td><td>1254</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result4_attr13">ABSOLUTE MONOCYTES</td><td>228</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result4_attr14">ABSOLUTE EOSINOPHILS</td><td>977</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result4_attr15">ABSOLUTE BASOPHILS</td><td>30</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result4_attr16">NEUTROPHILS</td><td>34.5</td><td/><td/></tr><tr><td ID="result4_attr17">LYMPHOCYTES</td><td>33.0</td><td/><td/></tr><tr><td ID="result4_attr18">MONOCYTES</td><td>6.0</td><td/><td/></tr><tr><td ID="result4_attr19">EOSINOPHILS</td><td>25.7</td><td/><td/></tr><tr><td ID="result4_attr20">BASOPHILS</td><td>0.8</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span><br/>Reviewed date:[REDACTED] 03:47:38 PM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result5_attr1">COLOR</td><td>TNP</td><td/><td ID="result5_attr1_notes"><p>TEST NOT PERFORMED</p><p>No specimen received.</p></td></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 12:10:13 PM<br/>Interpretation:High<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING<br/>NON-FASTING</td></tr><tr><td ID="result6_attr1">HEMOGLOBIN A1c</td><td>6.1</td><td>&lt;5.7 % of total Hgb</td><td ID="result6_attr1_notes"><p>A1c value between 5.7% and 6.4% is consistent with</p><p>For someone without known diabetes, a hemoglobin</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p><p>For someone with known diabetes, a value &lt;7%</p><p>This assay result is consistent with an increased risk</p><p>shifted HbA1c results compared to historical results.</p><p>Effective [REDACTED] a change in test platforms may have</p><p>targets should be individualized based on duration of</p><p>of diabetes.</p><p>considerations.</p><p>HbA1c performed on Roche platform.</p><p>diabetes, age, comorbid conditions, and other</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>indicates that their diabetes is well controlled. A1c</p><p>Currently, no consensus exists regarding use of</p></td></tr><tr><td colspan="4"><span class="content_span">CLIENT EDUCATION TRACKING</span><br/>Reviewed date:[REDACTED] 09:28:03 AM<br/>Interpretation:<br/>Performing Lab:TP, Quest Diagnostics-[REDACTED]
[REDACTED][REDACTED][REDACTED] [REDACTED] MD<br/>Notes/Report:<br/>FASTING: NO</td></tr><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span><br/>Reviewed date:[REDACTED] 09:28:03 AM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>FASTING: NO<br/>FASTING: NO</td></tr><tr><td ID="result8_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td/></tr><tr><td ID="result8_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result8_attr3">SPECIFIC GRAVITY</td><td>1.010</td><td>1.001-1.035</td><td/></tr><tr><td ID="result8_attr4">PH</td><td>8.5</td><td>5.0-8.0</td><td/></tr><tr><td ID="result8_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr9">PROTEIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr11">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result8_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result8_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td/></tr><tr><td ID="result8_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result8_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td/></tr><tr><td ID="result8_attr16">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 09:43:02 AM<br/>Interpretation:High<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING</td></tr><tr><td ID="result9_attr1">HEMOGLOBIN A1c</td><td>6.2</td><td>&lt;5.7 % of total Hgb</td><td ID="result9_attr1_notes"><p/><p>comparisons between historical and current results for</p><p>considerations.</p><p>indicates that their diabetes is well controlled. A1c</p><p>[REDACTED] Architect to the Roche cobas c503 may have shifted</p><p>Quest, the Roche platform relative to the [REDACTED]</p><p>variability established by the National Glycohemoglobin</p><p>Effective [REDACTED], a change in test platforms from the</p><p>prediabetes and should be confirmed with a</p><p>Standardization Program. Note that not all individuals</p><p>HbA1c results compared to historical results.</p><p>testing conducted on different platforms is not</p><p>platform had an average increase in HbA1c value of</p><p>targets should be individualized based on duration of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>Currently, no consensus exists regarding use of</p><p>Based on laboratory validation testing conducted at</p><p>For someone without known diabetes, a hemoglobin</p><p>follow-up test.</p><p>of diabetes.</p><p>recommended.</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>will have had a shift in their results and direct</p><p>For someone with known diabetes, a value &lt;7%</p><p>This assay result is consistent with an increased risk</p><p>This test was performed on the Roche cobas c503 platform.</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>diabetes, age, comorbid conditions, and other</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 09:43:02 AM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING</td></tr><tr><td ID="result10_attr1">GLUCOSE</td><td>89</td><td>65-99 mg/dL</td><td ID="result10_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result10_attr2">UREA NITROGEN (BUN)</td><td>14</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result10_attr3">CREATININE</td><td>0.64</td><td>0.60-0.95 mg/dL</td><td/></tr><tr><td ID="result10_attr4">EGFR</td><td>88</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result10_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result10_attr5_notes"><p/><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result10_attr6">SODIUM</td><td>140</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result10_attr7">POTASSIUM</td><td>4.2</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result10_attr8">CHLORIDE</td><td>103</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result10_attr9">CARBON DIOXIDE</td><td>30</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result10_attr10">CALCIUM</td><td>9.7</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result10_attr11">PROTEIN, TOTAL</td><td>7.3</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result10_attr12">ALBUMIN</td><td>4.0</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result10_attr13">GLOBULIN</td><td>3.3</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result10_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.2</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result10_attr15">BILIRUBIN, TOTAL</td><td>0.5</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result10_attr16">ALKALINE PHOSPHATASE</td><td>39</td><td>37-153 U/L</td><td/></tr><tr><td ID="result10_attr17">AST</td><td>16</td><td>10-35 U/L</td><td/></tr><tr><td ID="result10_attr18">ALT</td><td>11</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD (7600)</span><br/>Reviewed date:[REDACTED] 09:43:02 AM<br/>Interpretation:Normal<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING</td></tr><tr><td ID="result11_attr1">CHOLESTEROL, TOTAL</td><td>152</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result11_attr2">HDL CHOLESTEROL</td><td>75</td><td>&gt; OR = 50 mg/dL</td><td/></tr><tr><td ID="result11_attr3">TRIGLYCERIDES</td><td>56</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result11_attr4">LDL-CHOLESTEROL</td><td>63</td><td/><td ID="result11_attr4_notes"><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p><p>with &gt; or = 2 CHD risk factors.</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>estimation of LDL-C.</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>LDL-C is now calculated using the [REDACTED]</p><p>Reference range: &lt;100</p></td></tr><tr><td ID="result11_attr5">CHOL/HDLC RATIO</td><td>2.0</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result11_attr6">NON HDL CHOLESTEROL</td><td>77</td><td>&lt;130 mg/dL (calc)</td><td ID="result11_attr6_notes"><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>appt now, referral wasnt put in at her last appt , -pending notes [REDACTED] | will approve only this one visit because appt is [REDACTED] and pt on her way, pt notified needs referral prior next visit and switch to PPN</td></tr><tr><th>Diagnosis 1</th><td>Radiculopathy, cervical region (M54.12)</td></tr><tr><th>Diagnosis 2</th><td>Lumbar radiculopathy, chronic (M54.16)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider Specialty</th><td>Pain Medicine</td></tr><tr><th>Referral Priority</th><td>Stat</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>new pt changed provider in our ppn. </td></tr><tr><th>Diagnosis 1</th><td>Lumbar radiculopathy, chronic (M54.16)</td></tr><tr><th>Diagnosis 2</th><td>Radiculopathy, cervical region (M54.12)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Pain Medicine</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Follow up  (request and last notes attached) </td></tr><tr><th>Diagnosis 1</th><td>Lumbar radiculopathy, chronic (M54.16)</td></tr><tr><th>Diagnosis 2</th><td>Radiculopathy, cervical region (M54.12)</td></tr><tr><th>Diagnosis 3</th><td>Neuropathy (G62.9)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Pain Medicine</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>NSU Eye Care Institute</td></tr><tr><th>Diagnosis 1</th><td>Glaucoma screening (Z13.5)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider Specialty</th><td>Ophthalmology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Follow up (req and last notes attached)</td></tr><tr><th>Diagnosis 1</th><td>Lumbar radiculopathy, chronic (M54.16)</td></tr><tr><th>Diagnosis 2</th><td>Radiculopathy, cervical region (M54.12)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Pain Medicine</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 10:23:17 AM &gt;faxed to provider</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>follow up visit</td></tr><tr><th>Diagnosis 1</th><td>Syncope, unspecified syncope type (R55)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>Donk</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Cardiology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 12:31:21 PM &gt;approved and faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>f/u hx a.fib </td></tr><tr><th>Diagnosis 1</th><td>Well adult exam (Z00.00)</td></tr><tr><th>Diagnosis 2</th><td>Hx of syncope (Z87.898)</td></tr><tr><th>Diagnosis 3</th><td>HISTORY OF ATRIAL FIBRILLATION (Z86.79)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Cardiology</td></tr><tr><th>Procedure 1</th><td>-ELECTROCARDIOGRAM, COMPLETE (93000)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:53:35 PM &gt;approved and faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Follow up -request and notes attached | need notes</td></tr><tr><th>Diagnosis 1</th><td>Hypothyroidism, unspecified type (E03.9)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Endocrinology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 03:58:27 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Follow up - req attached</td></tr><tr><th>Diagnosis 1</th><td>Osteoarthritis, unspecified osteoarthritis type, unspecified site (M19.90)</td></tr><tr><th>Diagnosis 2</th><td>Polyneuropathy, unspecified (G62.9)</td></tr><tr><th>Diagnosis 3</th><td>Lumbar radiculopathy, chronic (M54.16)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Pain Medicine</td></tr><tr><th>Procedure 1</th><td>DRUG TEST PRSMV DIR OPT OBS (80305)</td></tr><tr><th>Procedure 2</th><td>Drug test def 1-7 classes (G0480)</td></tr><tr><th>Procedure 3</th><td>Drug test def 8-14 classes (G0481)</td></tr><tr><th>Procedure 4</th><td>Drug test def 15-21 classes (G0482)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 12:06:11 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Patient refuses any other medication. Discusses duloxetine and increasing gabapentin. Patient states she doesn't want any more medications since they have side effects and would lie to go back to a neurologist that she saw a few years back | [REDACTED] [REDACTED]</td></tr><tr><th>Diagnosis 1</th><td>Neuropathy (G62.9)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>Donk</td></tr><tr><th>Referring Provider Speciality</th><td>Nurse Practitioner</td></tr><tr><th>Referred Provider Specialty</th><td>Neurology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>thryoid nodule &gt;2.2 cm x 1.5cm for further eval</td></tr><tr><th>Diagnosis 1</th><td>Thyroid nodule (E04.1)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Endocrinology</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 01:54:07 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Follow up</td></tr><tr><th>Diagnosis 1</th><td>Osteoarthritis, unspecified osteoarthritis type, unspecified site (M19.90)</td></tr><tr><th>Diagnosis 2</th><td>Neuropathy (G62.9)</td></tr><tr><th>Diagnosis 3</th><td>Lumbar radiculopathy, chronic (M54.16)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation State Rd. 7</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Physical Medicine and Rehabilitation</td></tr><tr><th>Procedure 1</th><td>DRUG TEST PRSMV CHEM ANLYZR (80307)</td></tr><tr><th>Procedure 2</th><td>Drug test def 1-7 classes (G0480)</td></tr><tr><th>Procedure 3</th><td>Drug test def 8-14 classes (G0481)</td></tr><tr><th>Procedure 4</th><td>Drug test def 15-21 classes (G0482)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 09:11:23 AM &gt;faxed</td></tr><tr><th>Clinical Notes</th><td>[REDACTED] [REDACTED] 04:33:03 PM &gt;Not Motion appropriate: neuropathy. Redirected to RC</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Rosuvastatin Calcium 10 MG</td><td ID="instruction1">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Cyclobenzaprine HCl 5 MG</td><td ID="instruction2">1 tablet at bedtime as needed Orally Once a day for 30 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication3">traMADol HCl 50 MG</td><td ID="instruction3">TAKE 1 TABLET BY MOUTH TWICE A DAY AS NEEDED FOR 30 DAYS Oral twice a day as needed for 7 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication4">Anusol-HC 2.5 %</td><td ID="instruction4">1 application Externally Twice a day for 14 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication5">Gabapentin 600 MG</td><td ID="instruction5">1 tablet Orally tid for 30 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication6">DULoxetine HCl 60 MG</td><td ID="instruction6">1 capsule Orally Once a day</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication7">Pantoprazole Sodium 40 MG</td><td ID="instruction7">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication8">Medrol 4 MG</td><td ID="instruction8">as directed Orally as directed for 7 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication9">Gabapentin 300 MG</td><td ID="instruction9">1 capsule Orally three times a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Sucralfate 1 GM</td><td ID="instruction10">1 tablet on an empty stomach Orally Twice a day for 90 days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication11">Metoprolol Tartrate 25 MG</td><td ID="instruction11">TAKE 1/2 TABLET BY MOUTH EVERY 12 HOURS WITH FOOD for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Lidocaine 5 %</td><td ID="instruction12">1 patch remove after 12 hours Externally Once a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div>No Information</div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Female</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>55146009</td><td ID="Problem1">Sacroiliitis, not elsewhere classified (M46.1)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems1notes"><p>per</p><p>Pain Management [REDACTED] [REDACTED], follows up with pain management, stable pn OTC med.</p></td></tr><tr><td>Problem</td><td>267434003</td><td ID="Problem2">Mixed hyperlipidemia (E78.2)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems2notes">LDL 53(2/23) 63(3/24) advised on a low cholesterol diet, exercise as tolerated. Monitor lipid panel. on statin: Rosuvastatin 10 mg.</td></tr><tr><td>Problem</td><td>34713006</td><td ID="Problem3">Vitamin D deficiency (E55.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems3notes">serum vitamin d level 66 (6/23), stable.</td></tr><tr><td>Problem</td><td>165517008</td><td ID="Problem4">Neutropenia, unspecified type (D70.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems4notes">Absolute Neutrophils: 1311 ([REDACTED]),will monitor</td></tr><tr><td>Problem</td><td>237495005</td><td ID="Problem5">Thyroid nodule (E04.1)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems5notes"><p>as per BH hospital records</p><p>repeat us ordered</p></td></tr><tr><td>Problem</td><td>698247007</td><td ID="Problem6">Cardiac arrhythmia, unspecified cardiac arrhythmia type (I49.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems6notes">As per previous medical records. Patient on metoprolol. Denies any CP, palpitations</td></tr><tr><td>Problem</td><td>38341003</td><td ID="Problem7">Hypertension, unspecified type (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems7notes">Blood pressure at goal of &lt;140/90.  Advised on a low sodium diet, exercise as tolerated, avoid caffeine and alcohol, continue on Metoprolol 25 mg.</td></tr><tr><td>Problem</td><td>312442005</td><td ID="Problem8">HISTORY OF ATRIAL FIBRILLATION (Z86.79)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems8notes">short run during exercise stress test completely resolved quickly and advised no need for treatment</td></tr><tr><td>Problem</td><td>[REDACTED]</td><td ID="Problem9">Hx of syncope (Z87.898)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>35498005</td><td ID="Problem10">Venous stasis dermatitis of right lower extremity (I87.2)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems10notes">Patient follows up with dermatology. She has a cream she applies but does not remember the name.Doppler negative. Still pending follow up with dermatology</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>60 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>74 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Oximetry</th><td>99 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Height-cm</th><td>170.18 cm</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Weight-kg</th><td>71.21 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Height</th><td>67 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Blood pressure systolic</th><td>120 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">Weight</th><td>157 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital10">BMI</th><td>24.59 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure2">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure3">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure4">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure5">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure6">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure7">HEDIS: TRC MRP</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure8">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure9">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure10">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure11">HEDIS: COA Functional Status</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure12">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure13">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure14">HEDIS: DM A1C Controlled under 7.0</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure15">HEDIS: Depression Screening (If completed)</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure16">HEDIS: COA Pain Present</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure17">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure18">HEDIS: Fall Risk (If completed)</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure19">HEDIS: Advanced Care Planning</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure20">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure21">HEDIS: Depression Screening - Negative</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure22">HEDIS: Fall Risk - No Falls or 1 fall</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure23">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure24">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure25">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure26">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure27">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure28">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure29">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure30">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure31">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure32">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Thyroid nodule E04.1</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hospital discharge follow-up Z09 ; Hx of syncope Z87.898 ; Hypertension, unspecified type I10 and Body mass index [BMI] 24.0-24.9, adult Z68.24</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Well adult exam Z00.00 ; Venous stasis dermatitis of right lower extremity I87.2 ; Hypertension, unspecified type I10 ; Osteoarthritis, unspecified osteoarthritis type, unspecified site M19.90 ; Mixed hyperlipidemia E78.2 ; Thyroid nodule E04.1 ; Neuropathy G62.9 ; Vitamin D deficiency E55.9 ; Cardiac arrhythmia, unspecified cardiac arrhythmia type I49.9 ; Neutropenia, unspecified type D70.9 ; BMI 25-25.9 Z68.25 ; HISTORY OF ATRIAL FIBRILLATION Z86.79 and Prediabetes R73.03</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertension, unspecified type I10 ; Osteoarthritis, unspecified osteoarthritis type, unspecified site M19.90 ; Cardiac arrhythmia, unspecified cardiac arrhythmia type I49.9 ; Prediabetes R73.03 ; Encounter for screening for other suspected endocrine disorder Z13.29 ; Mixed hyperlipidemia E78.2 and Body mass index [BMI] 24.0-24.9, adult Z68.24</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertension, unspecified type I10 ; Neuropathy G62.9 ; Mixed hyperlipidemia E78.2 ; Prediabetes R73.03 ; Sacroiliitis, not elsewhere classified M46.1 and BMI 24-24.9 Z68.24</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>BMI 24-24.9 Z68.24 ; Venous stasis dermatitis of right lower extremity I87.2 ; Hypertension, unspecified type I10 ; Osteoarthritis, unspecified osteoarthritis type, unspecified site M19.90 ; Mixed hyperlipidemia E78.2 ; Neuropathy G62.9 ; Thyroid nodule E04.1 ; Vitamin D deficiency E55.9 ; Neutropenia, unspecified type D70.9 ; HISTORY OF ATRIAL FIBRILLATION Z86.79 ; Sacroiliitis, not elsewhere classified M46.1 ; Prediabetes R73.03 ; Drug-induced constipation K59.03 and BLEEDING HEMORRHOIDS K64.9</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Mixed hyperlipidemia E78.2 ; Hypertension, unspecified type I10 ; Prediabetes R73.03 and Encounter for screening for other suspected endocrine disorder Z13.29</td></tr><tr><td>MCM Plantation State Rd. 7</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Well adult exam Z00.00 ; Mixed hyperlipidemia E78.2 ; Venous stasis dermatitis of right lower extremity I87.2 ; Hypertension, unspecified type I10 ; Osteoarthritis, unspecified osteoarthritis type, unspecified site M19.90 ; Thyroid nodule E04.1 ; Neuropathy G62.9 ; Vitamin D deficiency E55.9 ; Cardiac arrhythmia, unspecified cardiac arrhythmia type I49.9 ; Neutropenia, unspecified type D70.9 ; BMI 25-25.9 Z68.25 ; HISTORY OF ATRIAL FIBRILLATION Z86.79 and Prediabetes R73.03</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>BMI 24-24.9 (ICD-10 - Z68.24)</td><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td>Blood pressure at goal of &lt;140/90.  Advised on a low sodium diet, exercise as tolerated, avoid caffeine and alcohol, continue on Metoprolol 25 mg.</td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Venous stasis dermatitis of right lower extremity (ICD-10 - I87.2)</td><td>Patient follows up with dermatology. She has a cream she applies but does not remember the name.Doppler negative. Still pending follow up with dermatology</td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Thyroid nodule (ICD-10 - E04.1)</td><td><p>as per BH hospital records</p><p>repeat us ordered</p></td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Neuropathy (ICD-10 - G62.9)</td><td>Has not been taking her gabapentin regularly. Advised to take 3x daily. It was increased a few months by [REDACTED] to 600mg TID but patient did not start taking it. Advised to start taking as prescribed. Patient states she will. Patient refuses to start duloxetine again. Per patient she does not wish to take that many medications and would prefer to have another nerve conduction study done and be seen by a neurologist</td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td>Blood pressure at goal of &lt;140/90.  Advised on a low sodium diet, exercise as tolerated, avoid caffeine and alcohol</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Hospital discharge follow-up (ICD-10 - Z09)</td><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Hx of syncope (ICD-10 - Z87.898)</td><td><p>CT angio neg</p><p>follow up with cardiology outpatient</p><p>no more syncopal episode per patient</p></td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Well adult exam (ICD-10 - Z00.00)</td><td/><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Venous stasis dermatitis of right lower extremity (ICD-10 - I87.2)</td><td>Patient follows up with dermatology. She has a cream she applies but does not remember the name.Doppler negative. Still pending follow up with dermatology</td><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Well adult exam (ICD-10 - Z00.00)</td><td/><td/><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Osteoarthritis, unspecified osteoarthritis type, unspecified site (ICD-10 - M19.90)</td><td>Stable on current medications. Has not followed up with new pain management physician yet.</td><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td><p>Blood pressure at goal of &lt;140/90. Continue current regimen</p><p>advised on a low salt diet, exercise as tolerated, avoid caffeine and alcohol</p></td><td/><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td><p>Blood pressure at goal of &lt;140/90. Continue current regimen: Metoprolol (25 mg)</p><p>advised on a low salt diet, exercise as tolerated, avoid caffeine and alcohol</p></td><td/><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Cardiac arrhythmia, unspecified cardiac arrhythmia type (ICD-10 - I49.9)</td><td>As per previous medical records. Patient on metoprolol. Denies any CP, palpitations</td><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td/><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td><p>Blood pressure at goal of &lt;140/90. Continue current regimen: Metoprolol (25 mg)</p><p>advised on a low salt diet, exercise as tolerated, avoid caffeine and alcohol</p></td><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Venous stasis dermatitis of right lower extremity (ICD-10 - I87.2)</td><td/><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LDL 53(2/23) 63(3/24) advised on a low cholesterol diet, exercise as tolerated. Monitor lipid panel. on statin</td><td/><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Osteoarthritis, unspecified osteoarthritis type, unspecified site (ICD-10 - M19.90)</td><td>Stable on current medications. Has not followed up with new pain management physician yet.</td><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LDL 53(2/23) 63(3/24) advised on a low cholesterol diet, exercise as tolerated. Monitor lipid panel. on statin: Rosuvastatin 10 mg.</td><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Prediabetes (ICD-10 - R73.03)</td><td><p>A1C 6.2(3/24)</p><p>advised on a low carb diet and to exercise as tolerated, monitor.</p></td><td/><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Body mass index [BMI] 24.0-24.9, adult (ICD-10 - Z68.24)</td><td/><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Encounter for screening for other suspected endocrine disorder (ICD-10 - Z13.29)</td><td/><td/><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Osteoarthritis, unspecified osteoarthritis type, unspecified site (ICD-10 - M19.90)</td><td>Stable on current medications. Has not followed up with new pain management physician yet.</td><td/><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Hypertension, unspecified type (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Prediabetes (ICD-10 - R73.03)</td><td><p>A1C 5.8(2/23)</p><p>repeat A1C</p></td><td/><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Encounter for screening for other suspected endocrine disorder (ICD-10 - Z13.29)</td><td/><td/><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>Osteoarthritis, unspecified osteoarthritis type, unspecified site (ICD-10 - M19.90)</td><td/><td/><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td><p>LDL 53(2/23)</p><p>advised on a low cholesterol diet, exercise as tolerated. Monitor lipid panel</p></td><td/><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Sacroiliitis, not elsewhere classified (ICD-10 - M46.1)</td><td><p>per</p><p>Pain Management [REDACTED] [REDACTED]</p><p>follows up with pain management</p></td><td/><td/></tr><tr><td ID="ref35">[REDACTED]</td><td>Neuropathy (ICD-10 - G62.9)</td><td>Has not been taking her gabapentin regularly. Advised to take 3x daily. It was increased a few months by [REDACTED] to 600mg TID but patient did not start taking it. Advised to start taking as prescribed. Patient states she will. Patient refuses to start duloxetine again. Per patient she does not wish to take that many medications and would prefer to have another nerve conduction study done and be seen by a neurologist</td><td/><td/></tr><tr><td ID="ref36">[REDACTED]</td><td>BMI 24-24.9 (ICD-10 - Z68.24)</td><td/><td/><td/></tr><tr><td ID="ref37">[REDACTED]</td><td>Thyroid nodule (ICD-10 - E04.1)</td><td><p>as per BH hospital records</p><p>repeat us ordered</p></td><td/><td/></tr><tr><td ID="ref38">[REDACTED]</td><td>Thyroid nodule (ICD-10 - E04.1)</td><td><p>as per BH hospital records</p><p>repeat us ordered</p></td><td/><td/></tr><tr><td ID="ref39">[REDACTED]</td><td>Thyroid nodule (ICD-10 - E04.1)</td><td/><td/><td/></tr><tr><td ID="ref40">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td><p>LDL 53(2/23)</p><p>advised on a low cholesterol diet, exercise as tolerated. Monitor lipid panel</p></td><td/><td/></tr><tr><td ID="ref41">[REDACTED]</td><td>Body mass index [BMI] 24.0-24.9, adult (ICD-10 - Z68.24)</td><td/><td>current w all preventive care, age appropriate cancer screening, and vaccination.</td><td/></tr><tr><td ID="ref42">[REDACTED]</td><td>Neuropathy (ICD-10 - G62.9)</td><td/><td/><td/></tr><tr><td ID="ref43">[REDACTED]</td><td>Neuropathy (ICD-10 - G62.9)</td><td>stable with Gabapentin 300 mg.</td><td/><td/></tr><tr><td ID="ref44">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td>serum vitamin d level 66 (6/23), stable.</td><td/><td/></tr><tr><td ID="ref45">[REDACTED]</td><td>Neutropenia, unspecified type (ICD-10 - D70.9)</td><td>Absolute Neutrophils: 1311 ([REDACTED]),will monitor</td><td/><td/></tr><tr><td ID="ref46">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td>serum vitamin d level 66 (6/23), stable.</td><td/><td/></tr><tr><td ID="ref47">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td/><td/></tr><tr><td ID="ref48">[REDACTED]</td><td>Cardiac arrhythmia, unspecified cardiac arrhythmia type (ICD-10 - I49.9)</td><td/><td/><td/></tr><tr><td ID="ref49">[REDACTED]</td><td>Cardiac arrhythmia, unspecified cardiac arrhythmia type (ICD-10 - I49.9)</td><td>As per previous medical records. Patient on metoprolol. Denies any CP, palpitations</td><td/><td/></tr><tr><td ID="ref50">[REDACTED]</td><td>HISTORY OF ATRIAL FIBRILLATION (ICD-10 - Z86.79)</td><td>short run during exercise stress test completely resolved quickly and advised no need for treatment</td><td/><td/></tr><tr><td ID="ref51">[REDACTED]</td><td>Sacroiliitis, not elsewhere classified (ICD-10 - M46.1)</td><td><p>per</p><p>Pain Management [REDACTED] [REDACTED], follows up with pain management, stable pn OTC med.</p></td><td/><td/></tr><tr><td ID="ref52">[REDACTED]</td><td>Neutropenia, unspecified type (ICD-10 - D70.9)</td><td/><td/><td/></tr><tr><td ID="ref53">[REDACTED]</td><td>Neutropenia, unspecified type (ICD-10 - D70.9)</td><td>Absolute Neutrophils: 1311 ([REDACTED]),will monitor</td><td/><td/></tr><tr><td ID="ref54">[REDACTED]</td><td>BMI 25-25.9 (ICD-10 - Z68.25)</td><td/><td/><td/></tr><tr><td ID="ref55">[REDACTED]</td><td>BMI 25-25.9 (ICD-10 - Z68.25)</td><td/><td/><td/></tr><tr><td ID="ref56">[REDACTED]</td><td>Prediabetes (ICD-10 - R73.03)</td><td>cont low sugar diet ,f/u hga1c</td><td/><td/></tr><tr><td ID="ref57">[REDACTED]</td><td>Drug-induced constipation (ICD-10 - K59.03)</td><td>mproved with milk of magnesia</td><td/><td/></tr><tr><td ID="ref58">[REDACTED]</td><td>HISTORY OF ATRIAL FIBRILLATION (ICD-10 - Z86.79)</td><td/><td/><td/></tr><tr><td ID="ref59">[REDACTED]</td><td>HISTORY OF ATRIAL FIBRILLATION (ICD-10 - Z86.79)</td><td>short run during exercise stress test completely resolved quickly and advised no need for treatment</td><td/><td/></tr><tr><td ID="ref60">[REDACTED]</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td/><td/></tr><tr><td ID="ref61">[REDACTED]</td><td>Prediabetes (ICD-10 - R73.03)</td><td>advised low sugar diet and walking, monitor labs.</td><td/><td/></tr><tr><td ID="ref62">[REDACTED]</td><td>BLEEDING HEMORRHOIDS (ICD-10 - K64.9)</td><td>anusol hc bid</td><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest11">HEDIS: COA Functional Status</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest12">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest13">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest14">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest15">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest16">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest17">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest18">HEDIS: COA Pain Present</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest19">HEDIS: Depression Screening (If completed)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest20">HEDIS: DM A1C Controlled under 7.0</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest21">HEDIS: Fall Risk (If completed)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest22">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest23">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest24">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest25">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest26">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest27">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest28">HEDIS: TRC MRP</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest29">HEDIS: Advanced Care Planning</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest30">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest31">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest32">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest33">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest34">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest35">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest36">HEDIS: Depression Screening - Negative</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest37">HEDIS: Fall Risk - No Falls or 1 fall</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest38">PREALBUMIN (4847)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest39">DEXA Hip and Spine</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest40">Venous Doppler</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest41">Ultrasound : Artery Doppler Low Ext Bilat</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest42">MAMMOGRAM</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest43">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest44">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest45">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest46">HEDIS: Blood Pressure Systolic &lt; 130</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest47">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest48">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest49">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest50">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest51">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest52">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED]-3717, [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 02:00:00 PM, [REDACTED]-3717, [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Aetna Medicare HMO (CAP)</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>101584588300</td><td/><td>[REDACTED], Snova</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>Arthritis</td><td/></tr><tr><td>Diverticulosis</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>HYSTERECTOMY TOTAL</td><td/></tr><tr><td>COLON resection</td><td/></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>GI BLEED ; BROWARD HEALTH</td><td>05/2022</td></tr></tbody></table></div><br/><br/>
</body></html>